Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor γ for monocyte recruitment and endothelial regeneration

European Journal of Pharmacology

Volumn 508, Issue 1-3, 2005, Pages 255-265

  Tanaka, Tokuji ^a   Fukunaga, Yasutomo ^a   Itoh, Hiroshi ^a   Doi, Kentaro ^a   Yamashita, Jun ^a   Chun, Tae Hwa ^a   Inoue, Mayumi ^a   Masatsugu, Ken ^a   Saito, Takatoshi ^a   Sawada, Naoki ^a   Sakaguchi, Satsuki ^a   Arai, Hiroshi ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CCR2; Insulin resistance; Macrophage; MCP 1; PPAR ; Thiazolidinedione

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CHEMOKINE RECEPTOR CCR2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; TROGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MACROPHAGE; MALE; MONOCYTE; MONOCYTIC LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; RABBIT;

ANGIOPLASTY, BALLOON; ANIMALS; AORTA; ARTERIOSCLEROSIS; BINDING, COMPETITIVE; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CCL2; CHROMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES; MALE; MONOCYTES; PPAR GAMMA; PROSTAGLANDIN D2; RABBITS; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLIDINEDIONES; TIME FACTORS; TRETINOIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 19944433644     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.10.056     Document Type: Article

References (28)

1. L. Boring, J. Gosling, S.W. Chensue, S.L. Kunkel, R.V. Farese Jr., H.E. Broxmeyer, and I.F. Charo Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice J. Clin. Invest. 100 1997 2552 2561
2. L. Boring, J. Gosling, M. Cleary, and I.F. Charo Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis Nature 394 1998 894 897
3. I.F. Charo, S.J. Myers, A. Herman, C. Franci, A.J. Connolly, and S.R. Coughlin Molecular cloning and functional expression of two monocyte chemoattractant protein-1 receptors reveals alternative splicing of the carboxyl-terminal tails Proc. Natl. Acad. Sci. U. S. A. 191 1994 2752 2756
4. Z. Chen, S. Ishibashi, S. Perrey, J. Osuga, T. Gotoda, T. Kitamine, Y. Tamura, H. Okazaki, N. Yahagi, Y. Iizuka, F. Shionoiri, K. Ohashi, K. Harada, H. Shimano, R. Nagai, and N. Yamada Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice Arterioscler. Thromb. Vasc. Biol. 21 2001 372 377
5. A.R. Collins, W.P. Meehan, U. Kintscher, S. Jackson, S. Wakino, G. Noh, W. Palinski, W.A. Hsueh, and R.E. Law Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice Arterioscler. Thromb. Vasc. Biol. 21 2001 365 371
6. R.A. DeFronzo, and E. Ferrannini Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease Diabetes Care 14 1991 173 194
7. K. Doi, T. Ikeda, H. Itoh, K. Ueyama, K. Hosoda, Y. Ogawa, J. Yamashita, T.-H. Chun, M. Inoue, K. Masatsugu, N. Sawada, Y. Fukunaga, T. Saito, M. Sone, K. Yamahara, H. Kook, M. Komeda, M. Ueda, and K. Nakao C-type natriuretic peptide induces re-differentiation of vascular smooth muscle cells with accelerated re-endothelialization Arterioscler. Thromb. Vasc. Biol. 21 2001 930 936
8. Y. Fukunaga, H. Itoh, K. Doi, T. Tanaka, J. Yamashita, T.-H. Chun, M. Inoue, K. Masatsugu, N. Sawada, T. Saito, K. Hosoda, H. Kook, M. Ueda, and K. Nakao Thiazolidinediones, peroxisome proliferator-activated receptor γ agonists, regulate endothelial cell growth and secretion of vasoactive peptides Atherosclerosis 158 2001 113 119
9. L. Gu, Y. Okada, S.K. Clinton, C. Gerard, G.K. Sukhova, P. Libby, and B.J. Rollins Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice Mol. Cell 2 1998 275 281
10. K.H. Han, M.K. Chang, A. Boullier, S.R. Green, A. Li, C.K. Glass, and O. Quenhenberger Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor-γ J. Clin. Invest. 106 2000 793 802
11. M. Inoue, H. Itoh, M. Ueda, T. Naruko, A. Kojima, R. Komatsu, K. Doi, Y. Ogawa, N. Tamura, K. Takaya, T. Igaki, J. Yamashita, T.-H. Chun, K. Masatsugu, A.E. Becker, and K. Nakao Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis Circulation 98 1998 2108 2116
12. M. Inoue, H. Itoh, T. Tanaka, T.-H. Chun, K. Doi, Y. Fukunaga, N. Sawada, J. Yamashita, K. Masatsugu, T. Saito, S. Sakaguchi, M. Sone, K. Yamahara, T. Yurugi, and K. Nakao Oxidized low density lipoprotein regulates VEGF expression in human macrophages and endothelial cells through activation of PPARγ Arterioscler. Thromb. Vasc. Biol. 21 2001 560 566
13. H. Itoh, K. Doi, T. Tanaka, Y. Fukunaga, K. Hosoda, G. Inoue, H. Nishimura, Y. Yoshimasa, Y. Yamori, and K. Nakao Hypertension and insulin resistance-the role of peroxisome proliferator-activated receptor-γ Clin. Exp. Pharmacol. Physiol. 26 1999 558 560
14. U. Kintscher, S. Goetze, S. Wakino, S. Kim, S. Nagpal, R.A.S. Chandraratna, K. Graf, E. Fleck, W.A. Hsueh, and R.E. Law Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes Eur. J. Pharmacol. 401 2000 259 270
15. R.E. Law, W.P. Meehan, X.-P. Xi, K. Graf, D.A. Wuthrich, W. Coats, D. Faxon, and W.A. Hsueh Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia J. Clin. Invest. 98 1996 1897 1905
16. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkinson, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) J. Biol. Chem. 270 1995 12953 12956
17. J. Minamikawa, S. Tanaka, M. Yamauchi, D. Inoue, and H. Koshiyama Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes J. Clin. Endocrinol. Metab. 83 1998 1818 1820
18. L. Nagy, P. Tontonoz, J.G.A. Alvarez, H. Chen, and R.M. Evans Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma Cell 93 1998 229 240
19. N.A. Nelken, S.R. Coughlin, D. Gordon, and J.N. Wilcox Monocyte chemoattractant protein-1 in human atheromatous plaques J. Clin. Invest. 88 1991 1121 1127
20. J.J. Nolan, B. Ludvik, P. Beerdsen, M. Joyce, and J. Olefsky Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone N. Engl. J. Med. 331 1994 1188 1193
21. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
22. N. Sawada, H. Itoh, K. Ueyama, J. Yamashita, K. Doi, T.-H. Chun, M. Inoue, K. Masatsugu, T. Saito, Y. Fukunaga, S. Sakaguchi, H. Arai, N. Ohno, M. Komeda, and K. Nakao Inhibition of Rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries Circulation 101 2000 2030 2033
23. M. Shiomi, T. Ito, T. Tsukada, Y. Tsujita, and H. Horikoshi Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits Atherosclerosis 142 1999 345 353
24. D. Skorjanc, F. Jaschinski, G. Heine, and D. Pette Sequential increases in capillarization and mitochondrial enzymes in low-frequency-stimulated rabbit muscle Am. J. Physiol. 274 1998 C810 C818
25. T. Tanaka, H. Itoh, K. Doi, Y. Fukunaga, K. Hosoda, M. Shintani, J. Yamashita, T.-H. Chun, M. Inoue, K. Masatsugu, N. Sawada, T. Saito, G. Inoue, H. Nishimura, Y. Yoshimasa, and K. Nakao Down regulation of peroxisome proliferator-activated receptor gamma expression by inflammatory cytokines and its reversal by thiazolidinediones Diabetologia 42 1999 702 710
26. P. Tontonoz, E. Hu, and B.M. Spiegelman Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor Cell 79 1994 1147 1156
27. P. Tontonoz, L. Nagy, J.G.A. Alvarez, V.A. Thomazy, and R.M. Evans PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL Cell 93 1998 241 252
28. L. Zhu, C.L. Bisgaier, M. Aviram, and R.S. Newton 9-Cis retinoic acid induces monocytes chemoattractant protein-1 secretion in human monocytic THP-1 cells Arterioscler. Thromb. Vasc. Biol. 19 1999 2105 2111